As of Apr 20
| -0.0113 / -1.99%|
The 1 analysts offering 12-month price forecasts for ARCA Biopharma Inc have a median target of 1.75, with a high estimate of 1.75 and a low estimate of 1.75. The median estimate represents a +213.68% increase from the last price of 0.56.
The current consensus among 1 polled investment analysts is to Buy stock in ARCA Biopharma Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.